<DOC>
	<DOCNO>NCT00824434</DOCNO>
	<brief_summary>Compile acute ( 30-day ) clinical outcome data 9-month angiographic intravascular ultrasound ( IVUS ) data PROMUS Element™ Everolimus- Eluting Coronary Stent System treatment patient single de novo atherosclerotic lesion</brief_summary>
	<brief_title>A Prospective , Multi-center Trial Assess Everolimus-Eluting Coronary Stent System ( PROMUS Element™ )</brief_title>
	<detailed_description />
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Atherosclerosis</mesh_term>
	<mesh_term>Everolimus</mesh_term>
	<criteria>Patient ( legal guardian ) understand study requirement treatment procedure provide write informed consent studyspecific test procedure perform Patient eligible percutaneous coronary intervention ( PCI ) Patient document stable angina pectoris ( Canadian Cardiovascular Society [ CCS ] Classification 1 , 2 , 3 , 4 ) document silent ischemia ; unstable angina pectoris ( Braunwald Class IBC , IIBC , IIIBC ) Patient acceptable candidate coronary artery bypass grafting ( CABG ) Patient leave ventricular ejection fraction ( LVEF ) &gt; =30 % measure within 30 day prior enrollment Patient willing comply specify followup evaluation Angiographic Target lesion must de novo lesion locate native coronary artery visually estimate diameter &gt; =2.25 mm &lt; =4.25 mm Target lesion length must measure ( visual estimate ) &lt; =34 mm Target lesion must major coronary artery branch visually estimate stenosis &gt; =50 % &lt; 100 % Thrombolysis Myocardial Infarction ( TIMI ) flow &gt; 1 . Patient clinical symptom and/or electrocardiogram ( ECG ) change consistent acute myocardial infarction ( MI ) Patient know diagnosis recent MI ( within 30 day prior index procedure ) elevate enzymes time index procedure follow . Patients exclude follow criterion meet time index procedure If creatine kinase , MB band ( CKMB ) &gt; 2× upper limit normal ( ULN ) , patient exclude regardless creatine kinase ( CK ) Total . If CKMB 12× ULN , patient exclude CK Total &gt; 2× ULN . If CK Total/CKMB use Troponin , patient exclude follow criterion meet time index procedure . Troponin &gt; 1× ULN least one follow . Patient ischemic symptom electrocardiogram ( ECG ) change indicative ongoing ischemia ( e.g. , &gt; 1mm ST segment elevation depression consecutive lead new left bundle branch block [ LBBB ] ) ; Development pathological Qwaves ECG Imaging evidence new loss viable myocardium new regional wall motion abnormality . Note : For patient recent MI , CK Total/CKMB ( Troponin CK Total/CKMB use ) must document prior enrol patient Patient receive organ transplant wait list organ transplant Patient receiving schedule receive chemotherapy within 30 day index procedure Patient receive oral intravenous immunosuppressive therapy ( ie , inhaled steroid exclude ) know lifelimiting immunosuppressive autoimmune disease ( e.g. , human immunodeficiency virus , systemic lupus erythematosus , include diabetes mellitus ) Patient receive chronic ( &gt; =72 hour ) anticoagulation therapy ( eg , heparin , coumadin ) indication acute coronary syndrome Patient platelet count &lt; 100,000 cells/mm3 &gt; 700,000 cells/mm3 Patient white blood cell ( WBC ) count &lt; 3,000 cells/mm3 Patient document suspect liver disease , include laboratory evidence hepatitis Patient dialysis know renal insufficiency ( i.e. , estimate creatinine clearance &lt; 50 mL/min Cockcroft Gault formula , ie [ ( 140age ) *lean body weight ( kg ) ] / [ plasma creatinine ( mg/dL ) *72 ] ) Patient history bleed diathesis coagulopathy refuse blood transfusion Patient cerebrovascular accident ( CVA ) transient ischemic attack ( TIA ) within past 6 month , permanent neurologic defect may cause noncompliance protocol Target vessel side branch treat type percutaneous coronary intervention ( PCI ; eg , balloon angioplasty , stent , cut balloon , atherectomy ) within 12 month prior index procedure Target vessel treat within 10 mm proximal distal target lesion ( visual estimate ) type PCI ( eg , balloon angioplasty , stent , cut balloon , atherectomy ) time prior index procedure Nontarget vessel side branch treat type PCI ( eg , balloon angioplasty , stent , cut balloon , atherectomy ) within 24 hour prior index procedure Planned actual target vessel treatment unapproved device , directional rotational coronary atherectomy , laser , cut balloon transluminal extraction catheter immediately prior stent placement Planned percutaneous coronary intervention coronary artery bypass graft index procedure Patient previously treat time coronary intravascular brachytherapy Patient know allergy study stent system protocolrequired concomitant medication ( e.g. , stainless steel , platinum , cobalt , chromium , nickel , tungsten , acrylic , fluoropolymers , everolimus , thienopyridines , aspirin , contrast ) adequately premedicated Patient active peptic ulcer active gastrointestinal ( GI ) bleed Patient one following : Other serious medical illness ( eg , cancer , congestive heart failure ) may reduce life expectancy le 24 month Current problem substance abuse ( eg , alcohol , cocaine , heroin , etc . ) Planned procedure may cause noncompliance protocol confound data interpretation Patient participate another investigational drug device clinical trial reach primary endpoint Patient intend participate another investigational drug device clinical trial within 12 month index procedure Known intention procreate within 12 month index procedure Female positive pregnancy test within 7 day prior index procedure ( pregnancy test must perform woman childbearing potential prior enrollment ) , lactate Patient 1 target lesion 1 target lesion 1 nontarget lesion , identify screen intervention Angiographic Target lesion meet follow criterion : Aortoostial location ( i.e. , lesion locate within 5 mm ostium ) Left main location Located within 5 mm origin leave anterior descending ( LAD ) coronary artery leave circumflex ( LCX ) coronary artery Located within saphenous vein graft arterial graft Can access via saphenous vein graft arterial graft Involves side branch &gt; =2.0 mm diameter Involves clinically significant side branch &lt; 2.0 mm diameter clinically significant stenosis ostium TIMI flow 0 ( total occlusion ) TIMI flow 1 prior wire cross Excessive tortuosity proximal within lesion Extreme angulation proximal within lesion Target lesion and/or target vessel proximal target lesion moderately severely calcify Restenotic previous intervention Thrombus , possible thrombus , present target vessel Patient additional clinically significant lesion ( ) target vessel intervention within 12 month index procedure likely require</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2012</verification_date>
	<keyword>Atherosclerosis</keyword>
	<keyword>Coronary Artery Disease</keyword>
</DOC>